Log in to save to my catalogue

Remyelination therapies: a new direction and challenge in multiple sclerosis

Remyelination therapies: a new direction and challenge in multiple sclerosis

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1917365589

Remyelination therapies: a new direction and challenge in multiple sclerosis

About this item

Full title

Remyelination therapies: a new direction and challenge in multiple sclerosis

Publisher

London: Nature Publishing Group UK

Journal title

Nature reviews. Drug discovery, 2017-09, Vol.16 (9), p.617-634

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Key Points
People with multiple sclerosis exhibit variable degrees of remyelination.
Individuals with greater capacity to remyelinate seem to have less clinical disability, thereby fuelling the research to find remyelination therapeutics for multiple sclerosis.
The biology of remyelination and its similarities and differences from developm...

Alternative Titles

Full title

Remyelination therapies: a new direction and challenge in multiple sclerosis

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_1917365589

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1917365589

Other Identifiers

ISSN

1474-1776

E-ISSN

1474-1784

DOI

10.1038/nrd.2017.115

How to access this item